FdaApplication
NDA 022291
Identifiers
- fda_app_no: NDA022291
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2008-11-20 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROMACTA | ELTROMBOPAG OLAMINE | EQ 25MG ACID | TABLET;ORAL |
| PROMACTA | ELTROMBOPAG OLAMINE | EQ 50MG ACID | TABLET;ORAL |
| PROMACTA | ELTROMBOPAG OLAMINE | EQ 75MG ACID | TABLET;ORAL |
| PROMACTA | ELTROMBOPAG OLAMINE | EQ 12.5MG ACID | TABLET;ORAL |
| PROMACTA | ELTROMBOPAG OLAMINE | EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
5 products